In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Koselugois a small molecule drug inhibitor targeting the MEK signaling pathway, ···【more】
Release date:2024-08-21Recommended:236
Koselugois a small molecule inhibitory drug targeting the MEK signaling pathway,···【more】
Release date:2024-08-21Recommended:274
Koselugo, as a small molecule blocker of the MEK signaling pathway, has a core e···【more】
Release date:2024-08-21Recommended:331
Koselugo is a small molecule inhibitor targeting the MEK signaling pathway, main···【more】
Release date:2024-08-21Recommended:299
Koselugo is a small molecule inhibitor targeting MEK, which plays the role of a ···【more】
Release date:2024-08-21Recommended:276
Koselugo is a small molecule MEK inhibitor and a repressor of mitogen activation···【more】
Release date:2024-08-21Recommended:291
Koselugois a small molecule MEK inhibitor (mitogen activation inhibitor), and it···【more】
Release date:2024-08-21Recommended:233
The therapeutic effect of Mitotane is aimed at adrenal cortical carcinoma, hyper···【more】
Release date:2024-08-20Recommended:302
Anamorelin is the first drug specifically for the treatment of cachexia launched···【more】
Release date:2024-08-20Recommended:215
In 2021, Japan launched Anamorelin, the world's first drug specifically for ···【more】
Release date:2024-08-20Recommended:315
Anamorelin is the world's first drug specifically for the treatment of cache···【more】
Release date:2024-08-20Recommended:290
In 2021, Ono Pharmaceutical of Japan launched Anamorelin, a ghrelin receptor ago···【more】
Release date:2024-08-20Recommended:371